Monocytes/Macrophages Mobilization Orchestrate Neovascularization after Localized Colorectal Irradiation.
In patients undergoing radiotherapy for cancer, radiation dose to healthy tissue can occur, causing microvascular damage. Monocytes that have been shown to promote tissue revascularization comprise the subsets: CD11b+Ly6G-7/4hi/monocyteshiand CD11b+Ly6G-7/4lo/monocyteslo. We hypothesized that monocytes were implicated in postirradiation blood vessel formation. C57Bl6 mice underwent localized colorectal irradiation and were sacrificed at different times after exposure. Bone marrow, spleen, blood and colon were collected. Fourteen days postirradiation, colons expressed proangiogenic actors and adhesion molecules. Monocyteshi, which were the main subset of infiltrating monocytes, mobilized to the blood from spleen and bone marrow, peaking at day 14 postirradiation, and were associated with lymphocyte Th1 polarization. At day 28 postirradiation, angiographic score and capillary density increased by ∼1.8-fold, and then returned to nonirradiated levels at day 60. Clodronate-mediated depletion of circulating monocytes prior to irradiation resulted in a ∼1.4-fold decrease in angiographic score and capillary density compared to the nontreated control. Histological analysis of the colon in clodronate-treated mice revealed a massive decrease of macrophage and lymphocyte infiltration as well as reduced collagen deposition in crypt area at day 21. However, late depletion of monocytes from day 25 postirradiation had no effect on fibrotic process. These findings demonstrate a central role for monocyte/macrophage activation in the orchestration of a neovascularization mechanism after localized colorectal irradiation.
a   Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM, SRBE, L3R, Fontenay-aux-Roses, France.
Céline
C
Loinard
b   Inserm UMR-U970, PARCC, Paris Research Cardiovascular Research Center, Paris, France.
José
J
Vilar
a   Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM, SRBE, L3R, Fontenay-aux-Roses, France.
Fabien
F
Milliat
c   Institut des Vaisseaux et du Sang, Paris, France.
Bernard
B
Lévy
d   Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM, SRBE, Fontenay-aux-Roses, France.
Marc
M
Benderitter
D000818:Animals; D002465:Cell Movement / Q000276:immunology / Q000528:radiation effects; D015179:Colorectal Neoplasms / Q000150:complications / Q000276:immunology* / Q000532:radiotherapy*; D005260:Female; D008262:Macrophage Activation / Q000276:immunology / Q000528:radiation effects; D008264:Macrophages / Q000276:immunology* / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000276:immunology* / Q000528:radiation effects; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000276:immunology* / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal / Q000009:adverse effects; D016896:Treatment Outcome